Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Business Model:
Revenue: $11.5M
Employees: 51-200
Address: Level 1 120 Jolimont Road
City: East Melbourne
State: victoria
Zip: 3002
Country: AU
Starfish Ventures is a venture capital firm. That specializes in seed, start-up, expansion, emerging growth, early venture, mid venture, late venture, growth capital, middle market, and buyouts investments. The company prefers to invests in life sciences, clean technology, materials science, and information technology. Within life sciences, it focuses on biotechnology, medical devices, therapeutics, and drug development. Within clean technology, the firm invests in energy, water, and other environmental technologies. Within information technology, it considers investments in software, mobile, Internet and cloud based enterprise systems, semiconductor, instrumentation, hardware, and telecommunications. It seeks to exit its investments through mergers and acquisitions, trade sale, or an initial public offer within two to five years. Starfish Ventures was founded by John Dyson and Michael Panaccio in 2001, and is headquartered in Melbourne, Australia.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2011 | DesignCrowd | Series A | 3M |
6/2008 | Audinate | Series A | 0 |
6/2013 | Aktana | Series A | 5.5M |
6/2008 | 5th Finger | Series A | 7M |
2/2015 | DesignCrowd | Series B | 4.7M |
6/2013 | Protagonist Therapeutics | Series B | 0 |
11/2008 | Evostor | Series A | 5M |
3/2006 | Qs Semiconductor Corporation | Venture Round | 1.3M |
5/2012 | Scalify | Series A | 2M |
4/2012 | Nitro | Series A | 3.5M |
9/2005 | Engana Pty | Series B | 0 |
3/2009 | Ofidium | Series A | 6M |
3/2010 | Evostor | Series A | 3M |
5/2012 | Aktana | Series A | 2M |
12/2006 | Quickcomm Software Solutions | Series A | 4.1M |
10/2012 | StreamShark | Series A | 2.3M |
3/2005 | G2 Microsystems | Series A | 0 |
1/2010 | Audinate | Venture Round | 0 |
2/2021 | DesignCrowd | Venture Round | 7.6M |
5/2011 | Ourcast | Seed Round | 1.3M |
8/2019 | Marani | Seed Round | 0 |
11/2006 | Intersection Medical Inc | Series B | 5M |
8/2014 | BugHerd | Series A | 929.6k |
8/2006 | ImpediMed | Venture Round | 3.4M |
10/2010 | ICIX | Series B | 6M |
7/2006 | G2 Microsystems | Series B | 14M |
6/2016 | Aktana | Series B | 17.6M |
1/2009 | ZoomSystems | Series E | 0 |
3/2012 | StyleTread | Series C | 12.4M |
1/2012 | BugHerd | Seed Round | 550k |
1/2007 | MuriGen | Series A | 3.9M |
11/2006 | Impedance Cardiology Systems | Series B | 5M |
6/2012 | UpGuard | Seed Round | 1.2M |
4/2009 | Ausra | Venture Round | 25.5M |
9/2005 | Xelor Software | Series B | 6M |
7/2015 | Protagonist Therapeutics | Series C | 0 |
11/2012 | Atmail | Venture Round | 2M |
2/2004 | Xelor Software | Series A | 4.7M |
10/2012 | Ourcast | Venture Round | 500k |
8/2011 | Aktana | Series A | 3M |
6/2008 | Aruspex | Series A | 3.8M |
9/2006 | Protagonist Therapeutics | Series A | 9M |
4/2005 | Distra | Venture Round | 3.9M |
10/2012 | MetaCDN | Series A | 2.3M |
2/2008 | Monitoring Division | Series A | 3.9M |
12/2008 | DorsaVI | Seed Round | - |
3/2008 | Holly Connects | Venture Round | - |
1/2012 | BugHerd | Venture Round | 550k |
9/2013 | Ourcast | Seed Round | 200k |
10/2013 | Nitro | Unattributed | 3.1M |
6/2012 | Bubble Gum Interactive | Series B | 2.5M |
11/2007 | Austhink Software | Series B | 3.8M |
2/2021 | DesignCrowd | Venture Round | 0 |
8/2019 | Marani | Seed Round | 0 |
6/2016 | Aktana | Series B | 0 |
7/2015 | Protagonist Therapeutics | Series C | 0 |
2/2015 | DesignCrowd | Series B | 0 |
8/2014 | BugHerd | Series A | 0 |
10/2013 | Nitro | Series A | 0 |
9/2013 | Ourcast | Seed Round | 0 |
6/2013 | Aktana | Series A | 0 |
6/2013 | Protagonist Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|